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1. Introduction 
The triple helical molecular conformation of colla- 
gen has been established with the aid of X-ray fibre 
diffraction patterns of the native protein and of 
various synthetic polytripeptide model compounds 
[l] . However, as fibre patterns provide only very 
limited data, it has so far been possible to determine 
only an average structure for the helical regions of the 
collagen molecule. Diffraction patterns of single crys- 
tals, on the other hand, generally provide many more 
data, and, if these were obtainable for collagen, they 
might make possible not only a test of the precision 
of the fibre structure determination, but also an inves- 
tigation of water binding and specific side-chain inter- 
actions, which have been suggested for several amino 
acid residues [2-41. 
Collagen molecules are some 3000 a long and 15 a 
in diameter, and each of their three polypeptide chains 
contain over 1000 amino acid residues. We have avoi- 
ded the formidable challenge of trying to crystallize 
complete molecules of such complexity and extreme 
asymmetry. However, encouraged by the crystalliza- 
tion of the collagen-like oligopeptide (Pro-Pro-Gly),, 
[5], we have attempted to crystallize peptide frag- 
ments derived from al(H) chains of chick cartilage 
collagen by cyanogen bromide (CNBr) cleavage at 
methionyl residues [6]. It has been shown that a 36- 
residue CNBr peptide of the al(I) chain of rat skin 
collagen can be renatured to form a collagen-like 
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trimer [7,8], and we have subjected several CNBr pep- 
tides derived from chick cartilage (ul(II) chains to 
similar renaturing conditions and subsequently suc- 
ceeded in growing crystals. Since the cartilage collagen 
molecule is comprised of three identical (ul(II) chains 
[9], the crystal structures should correspond to intact 
sections of the native molecule. 
2. Materials and methods 
CNBr peptides derived from (ul(I1) chains of chick 
sternal cartilage collagen were isolated and purified 
by ion-exchange and molecular sieve chromatography 
as previously described [6]. Peptides 6,7, 11, and 12, 
containing linear sequences of 33,44, 272, and 84 
amino acid residues, respectively, were used for crys- 
tallization studies. 
For renaturation, solutions of each peptide at a 
concentration of 35 mg/ml in 0.15 M potassium ace- 
tate, pH 4.8, were prepared and allowed to remain at 
2°C for at least 4 days [7,8]. The extent of renatura- 
tion was not ascertained. Prior to attempts at crys- 
tallization, the renatured peptide solutions were dilut- 
ed slightly to approximately 30 mg/ml by the addi- 
tion of 5.0 M NaCl to achieve a final NaCl concentra- 
tion of 0.4-0.5 M in the peptide solutions. Indeed, 
no crystals were obtained without the addition of this 
salt. As noted below, ammonium sulfate or 2-methoxy 
2,-4-pentane diol (MPD) were also added to the rena- 
tured peptide solutions in certain instances. 
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A wide variety of possible crystallization conditions 
were surveyed using the technique of slow vapor dif- 
fusion [lo] with a hanging drop of peptide solution. 
These experiments were performed using plastic multi- 
dish disposo-trays with 24 wells (Linbro Manufacturing 
Co.). Approximately 1.0 1.5 ml of solution to be 
assayed for ability to promote crystallization condi- 
tions was placed in each well. The ionic strength of 
the test solutions was varied between 0.5 and 3.0 M 
NaCl, and the solutions were employed over a variety 
of pH ranges for a given NaCl concentration. Buffers 
&ed for the various pH ranges were as follows: pH 
1.6-2.0, 0.15 M potassium chloride; pH 2.1-3.0, 
0.1 M potassium hydrogen phthalate-HCl, 0.15 M gly- 
tine hydrochloride or dilute acetic acid; pH 3.1.. 5.8, 
0.15 M sodium acetate or potassium acetate; pH 7.5- 
9.0,0.15 M ammonium chloride; and pH 9.1-l 1 .O, 
dilute ammonium hydroxide. The wells containing 
these solutions were then covered with a siliconized 
cover glass to which was attached a hanging drop 
(2.OG5.0 h) of peptide solution prepared as described 
above. Evaporation from the chambers was prevented 
by application of immersion oil between the edges of 
the depression and the cover glass. 
In an alternate crystallization procedure, 20 X of 
renatured peptide solution was placed in a perspex 
cell and covered by a dialysis membrane. The latter 
was held firmly in place by means of an O-ring fitted 
in a groove around the cell. Cells of this type were 
placed in vials containing 3.0-4.0 ml of possible crys- 
tallization solutions. The solutions assayed in this 
manner contained 0.5-3.0 M NaCl and were employed 
at two pH ranges: pH 6.5-8.2, 0.15 M phosphate 
buffer; and pH 7.0-9.1, 0.15 M tris hydrochloride. 
These cells require larger portions of peptide solutions 
than the depression chambers, but equilibrium con- 
ditions are approached more rapidly. They have the 
advantage that the dialysate can be changed easily 
allowing a step-by-step approach to crystallization. 
All samples for crystallization were stored at 2”C, 
and the first crystals generally appeared after a three 
day interval. The crystals were observed by light micro- 
scopy. 
3. Results 
Peptide 6. Clusters of small needle-like crystals 
(maximum length, approximately 0.05 mm) were 
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observed in the peptide solutions following exposure 
by vapor diffusion to solutions at pH values between 
1.7 and 3.2 and NaCl concentrations from 0.5 to 
1.4 M. Neither factor appeared to be critical, although 
the crystals grew more readily near the midpoint of 
the indicated pH and NaCl concentration ranges. 
Addition of ammonium sulfate 15% of saturation in 
the peptide solution and up to 50% of saturation in 
the well solution did not appear to affect crystaili- 
zation. Addition of MPD at a concentration of 10% 
in the peptide solution and from 10 to 40% in the 
well solution appeared to inhibit crystallization, and 
no crystals were formed over these ranges of pH and 
NaCl concentration. Similar clusters of very small 
needle-like crystals of renatured peptide 6 were 
obtained in two other instances: in vapor diffusion 
experiments when the solution in the well ranged in 
pH from 8.0 to 10.7 at an NaCl concentration of 1.5 
M; and during dialysis experiments when the dialy- 
sate was in the pH range of 7.2 to 8.2 and the NaCl 
concentration was in the range of 1.5-2.5 M. 
Peptide 7. Fairly large tabular or plate-like crystals 
up to 0.7 mm in length were obtained in vapor dif- 
fusion experiments with the well solution in the pH 
ranges of 2.6-3.0 and 7.5-9.0 at an NaCl concentra- 
tion of 0.5 M (fig. 1). Although crystals of renatured 
Kg. 1. Crystals of renatured peptide 7 derived from chick 
sternal cartilage oll(II) collagen chains. The crystals were 
gown at pH 8.0 (0.15 M ammonium chloride, 0.5 M N&l, 
35% ammonium sulfate). 
Volume 57, number 1 FEBS LETTERS September 1975 
peptide 7 were generally observed under these con- 
ditions, the largest crystals were obtained when ammoni- 
um sulfate was added at 15% and 35-650/o of satura- 
tion in the peptide drop and well solution, respectively. 
Somewhat smaller crystals of renatured peptide 7 
were also observed in dialysis experiments using solu- 
tions in the pH range of 7.6-9.1 and an NaCl concen- 
tration of 1.8 M. 
Peptide 11. Very small needle-like crystals were 
grown by vapor diffusion with the well solution at 
pH 2.6 and 0.7 M NaCl. Using the dialysis method, 
slightly larger crystals (maximum length, 0.5 mm) 
were obtained with the dialysate at pH 7.6 and 1.8 M 
NaCl. 
Peptide 12. Very small needle-like crystals were 
grown by vapor diffusion with the well solutions at 
pH 2.0-2.6 and 0.7 M NaCl as well as at pH 7.5- 10.7 
and 0.9-1.8 M NaCl. 
4. Discussion 
We have demonstrated that a number of renatured 
CNBr peptide fragments derived from collagen otl(II) 
chains can be induced to precipitate in crystalline 
form under a wide variety of conditions. Although the 
renatured peptides were not examined with respect 
to helical content and perfection of helix, the obser- 
vation that each renatured peptide could be induced 
to form crystals strongly suggests that virtually com- 
plete refolding with a structure very similar to the 
native configuration had been achieved. 
Our main interest in growing crystals of these rena- 
tured collagen peptides is, of course, the eventual 
determination of structure by X-ray crystallography. 
In this regard, the relatively large crystals observed 
for renatured peptide 7 show considerable promise 
provided they can be induced to grow somewhat 
thicker and remain stable at room temperature during 
the collection of X-ray diffraction data. Alternatively, 
it may be possible to collect diffraction data at suit- 
ably lower temperatures. 
Apart from the question of crystallizability, peptides 
6 and 7 are both attractive candidates for X-ray struc- 
ture analysis in that they have relatively low molecu- 
lar weights, approximately 10 000 and 12 000 res- 
pectively per trimer. Peptides 11 and 12 with trimer 
molecular weights of 75 000 and 24 000 respectively, 
would certainly prove to be much more difficult 
structures to analyse. They do, however, have an addi- 
tional interest in that each of these peptides contain 
several of the many residues of galactosylhydroxy- 
lysine and glucosylgalactosylhydroxylysine normally 
associated with collagen oll(lJ) chains (E.J. Miller, 
unpublished observations). Furthermore, in the case 
of peptide 11, there existis the possibility of achieving 
a staggered fibril-type assembly [ 111 . 
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